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Resistance to Adenovirally Induced Hyperleptinemia in Rats
Comparison of Ventromedial Hypothalamic Lesions and Mutated Leptin Receptors
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Satya P. Kalra,‡ Christopher B. Newgard,* and Roger H. Unger*§
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Medical Center, Dallas, Texas 75235; §Veterans Administration Medical Center, Dallas, Texas 75216; and ‡Department of Neuroscience,
University of Florida, College of Medicine, Gainesville, Florida 32610-0244

Abstract
Leptin regulates appetite and body weight via hypothalamic
targets, but it can act directly on cultured pancreatic islets
to regulate their fat metabolism. To obtain in vivo evidence
that leptin may act peripherally as well as centrally, we
compared the effect of adenovirally induced hyperleptinemia on food intake, body weight, and islet fat content in
ventromedial hypothalamic-lesioned (VMHL) rats, shamlesioned (SL) controls, and Zucker Diabetic Fatty (ZDF)
rats in which the leptin receptor is mutated. Infusion with
recombinant adenovirus containing the rat leptin cDNA increased plasma leptin by z 20 ng/ml in VMHL and ZDF
rats but had no effect on their food intake, body weight, or
fat tissue weight. Caloric matching of hyperphagic VMHL
rats to SL controls did not reduce their resistance to hyperleptinemia. Whereas prediabetic ZDF rats had a fourfold elevation in islet fat, in VMHL rats islet fat was normal and
none of them became diabetic. Isolated islets from ZDF rats
were completely resistant to the lipopenic action of leptin,
while VMHL islets exhibited 50% of the normal response;
caloric matching of VMHL rats to SL controls increased
leptin responsiveness of their islets to 92% of controls. We
conclude that leptin regulation of adipocyte fat requires an
intact VMH but that islet fat content is regulated independently of the VMH. (J. Clin. Invest. 1998. 102:728–733.) Key
words: leptin resistance • Zucker Diabetic Fatty (ZDF) rats
(fa/fa) • adenoviral gene transfer • islets • triglycerides

Introduction
The hypothalamus plays a crucial role in the control of food intake, thermogenesis, and body composition (1–8). The discovery of leptin (3) and neuropeptide Y (NP-Y) (4) have expanded our understanding of the mechanisms involved in
hypothalamic obesity. It has been established that the full-

Address correspondence to Roger H. Unger, M.D., Center for Diabetes Research, University of Texas Southwestern Medical Center,
5323 Harry Hines Boulevard, Dallas, TX 75235-8854. Phone: 214648-6742; FAX: 214-648-9191; E-mail: Runger@mednet.SWmed.edu
Received for publication 6 March 1998 and accepted in revised
form 10 June 1998.
J. Clin. Invest.
© The American Society for Clinical Investigation, Inc.
0021-9738/98/08/0728/06 $2.00
Volume 102, Number 4, August 1998, 728–733
http://www.jci.org
728

Koyama et al.

length leptin receptor isoform, OB-Rb,1 is preferentially expressed in the ventromedial hypothalamic (VMH) nucleus (5)
and that it downregulates the expression of the NP-Y gene,
which encodes an appetite-stimulating neuropeptide (6–8).
When leptin is deficient, as in ob/ob mice (3), when OB-Rb is
defective, as in db/db mice (9, 10), when all OB-R isoforms are
defective, as in the homozygous (fa/fa) Zucker Diabetic Fatty
(ZDF) rats (11, 12), or when the VMH nucleus is ablated (13),
hyperphagia and obesity ensue. However, the latter syndrome
differs from the three genetically determined syndromes in
that the loss of leptin action is presumably confined to the
ablated area and, unlike the genetic syndromes, should not
involve extrahypothalamic tissues that express the normal
OB-R. Furthermore, diabetes, which complicates all three of
the genetic forms of obesity, is reported not to occur in VMHlesioned (VMHL) animals (14).
Although an abundance of evidence points to leptin as the
principal signal to the hypothalamus for regulation of body
composition, leptin also has striking direct extraneural effects
on both adipocytes (15) and nonadipocytes (16, 17). For example, it lowers the fat content of isolated islets by directly upregulating the mRNA of enzymes of fatty acid oxidation, carnitine palmitoyl transferase-1 (CPT-1) and acyl-CoA oxidase
(ACO), and downregulating mRNA of enzymes of lipogenesis, fatty acid synthetase, fatty acyl-CoA synthetase, and glycerol-phosphate acyl transferase (18). There are also in vivo observations consistent with direct leptin action. For example,
when ectopic hyperleptinemia is induced by adenoviral transfer of the leptin cDNA into normal lean rats, all visible fat tissue disappears within 1 wk (19) and fat content falls dramatically in nonadipocytes as well (20); the disappearance of fat is
accompanied by the same increase in expression of genes encoding enzymes of fatty acid oxidation, CPT-1 and ACO (19),
as was observed in vitro.
In an attempt to determine if the rapid generalized fat depletion caused by ectopic hyperleptinemia is entirely mediated by
the VMH nucleus, we induced hyperleptinemia by adenoviral
leptin gene transfer in a group of VMHL rats. We had expected
that hyperphagia, which is clearly the result of the hypothalamic
lesion, would be resistant to the ectopic hyperleptinemia; however, given the presumed qualitative and quantitative integrity
of the extrahypothalamic leptin receptors, we expected that all

1. Abbreviations used in this paper: AdCMV-leptin, recombinant adenovirus containing the rat leptin cDNA under control of the CMV
promoter; AdCMV-bgal, recombinant adenovirus containing the
bacterial b-galactosidase gene under control of the CMV promoter;
OB-R, leptin receptor; OB-Rb, leptin receptor b isoform; SL, SLlesioned; TG, triglyceride; VMH, ventromedial hypothalamus;
VMHL, VMH-lesioned; ZDF, Zucker Diabetic Fatty.

OB-R–expressing peripheral tissues, including adipocytes,
would respond to the hyperleptinemia. This study was designed to test this prediction.

Methods
VMHL and sham-lesioned controls. This VMHL was performed at
the Department of Neuroscience, University of Florida (Gainesville,
FL) as approved by the University of Florida Institutional Animal
Care and Use Committee, which follows the National Institutes of
Health Guide for the Care and Use of Laboratory Animals. Adult
Sprague Dawley (HSD-HD; Harlan Sprague-Dawley, Indianapolis,
IN) male rats weighing 250–300 g were housed in air-conditioned
rooms (22–258C) with lights on from 0500–1900 h. Food and water
were available ad libitum. Rats were weighed and anesthetized with
sodium pentobarbital (50 mg/kg i.p.; Abbott Laboratories, North
Chicago, IL). The VMH was destroyed bilaterally by the previously
described electrolytic lesion procedure (21). Briefly, rats were placed
in the stereotaxic instrument and positioned with the nose bar set
3.3 mm below the interaural line. The electrode, consisting of an insulated stainless steel insect pin with exposed tip, was positioned 2.6 mm
behind the bregma, 0.6 mm lateral to the midline, and then lowered
to the base of the brain and then raised 0.5 mm. A direct anodal current of 2.5 mA for 15 s was passed through the electrode aimed at the
VMH with a rectal electrode serving as a cathode. For sham-lesioning
(SL), the same surgical procedures were performed except that no
current was passed. Rats were allowed to recover for approximately 1
wk before any further procedures were undertaken. They were then
flown to Dallas.
Animals. Homozygous (fa/fa) ZDF-drt rats were bred in our laboratory from [ZDF/Drt-fa(F10)] rats purchased from R. Peterson
(University of Indiana School of Medicine, Indianapolis, IN). 6- to
7-wk-old male ZDF (fa/fa) rats were used in this study. All Sprague
Dawley and ZDF (fa/fa) rats were studied in individual metabolic
cages (Nalgene, Rochester, NY), and body weight and food intake
were measured daily. Free-feeding rats were on standard chow
(model F6-8664; Teklad, Madison, WI) ad libitum and had free access
to water. Calorically matched rats received exactly the amount of
food consumed by the SL animals.
Leptin gene transfer. To induce hyperleptinemia in SL and
VMHL rats, recombinant adenovirus containing the rat leptin cDNA
(AdCMV-leptin) was prepared as previously described (19). Briefly,
a Bam HI– and Xba I–restricted leptin cDNA fragment that includes
60 bp of 59 untranslated region and 76 bp of 39 untranslated region
was ligated to similarly treated pACCMVpLpA. The resulting plasmid was cotransfected with pJM17 into 293 cells by calcium phosphate/DNA coprecipitation to generate the AdCMV-leptin. Stocks of
AdCMV-leptin were amplified and purified as described (22), and
then stored at 2708C in phosphate buffer solution with 0.2% bovine
serum albumin and 10% glycerol at 3 3 1012 pfu/ml. A virus containing the bacterial b-galactosidase gene under control of the CMV
promoter (AdCMV-bgal) was prepared and used as described previously (19). 2 ml of AdCMV-leptin or AdCMV-bgal viruses containing a total of 1012 pfu was infused into the right cervical vein of unconscious rats under sodium pentobarbital anesthesia (50 mg/kg, i.p.)
over 30 min.
Plasma measurements. Blood samples were collected from the
tail vein in capillary tubes coated with ethylenediaminetetraacetic
acid. Plasma was stored at 2208C. Plasma leptin was assayed by radioimmunoassay using the Linco leptin assay kit (Linco Research, St.
Charles, MO), and insulin radioimmunoassay was performed as previously described (19). Plasma glucose was measured by the glucose
oxidase method using a glucose analyzer (glucose analyzer II, Beckman, Brea, CA). Plasma free fatty acid levels were determined using
a kit from Boehringer Mannheim (Indianapolis, IN). Plasma triglyceride (TG) levels were measured with a TG kit (GPO-Trinder triglyceride kit; Sigma Chemical Co., St. Louis, MO).

Islet isolation and culture. Pancreatic islets were isolated according to the method of Naber et al. (23) with modifications. They were
maintained in suspension culture in 60-mm Petri dishes at 378C in a
humidified atmosphere of 5% CO2 and 95% air (24). The culture medium consisted of RPMI-1640 medium supplemented with 8.0 mM
glucose, 10% fetal bovine serum, 200 U/ml penicillin, 0.2 mg/ml streptomycin, and 2% bovine serum albumin, fraction V (Bayer, Kankakee, IL).
Tissue triglyceride content. After 3 days in culture, islets were
washed twice with Hank’s balanced salt buffer and suspended in 50 ml
of buffer (2 M NaCl/2 mM EDNA/50 mM sodium phosphate, pH
7.4). After sonication, 10 ml of the homogenate was mixed with 10 ml
of tert-butyl alcohol and 5 ml of a Triton X-100/methyl alcohol mixture (1:1 vol/vol). TG were extracted with 30 ml of tert-butyl alcohol
and 20 ml of a Triton X-104/methyl alcohol mixture (1:1 vol/vol). TG
content was measured by GPO-Trinder triglyceride kit. In other tissues, TG was measured by the same technique as described previously (20).
TG content in skeletal muscle and liver was measured as previously described (20).
Statistical analyses. All values shown are expressed as mean6
SEM. Statistical analysis was performed by two-tailed unpaired Student’s t test by one-way analysis of variance.

Results
Leptin levels. AdCMV-leptin was infused into lean SL rats,
obese VMHL rats, and obese ZDF (fa/fa) rats. As shown in
Fig. 1 A, baseline plasma leptin levels were elevated in VMHL

Figure 1. Plasma leptin levels in SL and VMHL Sprague Dawley rats
(A), and ZDF (fa/fa) rats (B) before and 14 days after AdCMV-leptin
or AdCMV-bgal infusion. Values represent the mean6SEM of five
experiments.
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and ZDF (fa/fa) animals, averaging 7.860.7 ng/ml and 7.660.2
ng/ml, respectively, on the day of viral infusion compared with
0.9860.1 ng/nl in SL rats (Fig. 1). In AdCMV-leptin–infused
VMHL rats, plasma leptin rose to 21.563.2 ng/ml on day 3 and
declined to 12.062 mg/ml on day 14 (Fig. 1 A). In ZDF (fa/fa)
rats infused with AdCMV-leptin, plasma leptin reached a peak
of 20.362.1 ng/ml on day 3 and averaged 14.861.9 ng/ml on
day 14 (Fig. 1 B).
Food intake, body weight, and plasma insulin levels. As expected, the food intake and body weight of VMHL rats increased significantly above that of SL rats (Fig. 2, A and B).
While both food intake and body weight were dramatically reduced in SL rats infused with AdCMV-leptin, in the AdCMVleptin–treated VMHL rats, neither food intake nor body
weight differed from untreated VMHL controls despite a
threefold rise in their previously elevated plasma leptin levels.
The weight of epididymal and retroperitoneal fat in VMHL
rats was significantly greater than that of SL controls and was
not reduced by the increase in hyperleptinemia. Plasma glucose of SL rats infused with AdCMV-leptin declined to
40.362.9 mg/dl on day 14, but there was no change in glucose
in VMHL rats (Fig. 2 C). As shown in Fig. 2, D–F, food intake,
body weight, and plasma glucose levels of ZDF (fa/fa) rats
were similarly resistant to the effects of the ectopic hyperleptinemia. The lack of a change in either food intake or body
weight in the hyperleptinemic VMHL rats indicated that both
the anorectic and adipocyte-wasting effects of hyperleptinemia
require an intact hypothalamus.
Fasting insulin levels averaged 23611.3 mU/ml in VMHL
rats infused with AdCMV-bgal compared with 11.661.9 mU/ml
in SL rats infused with AdCMV-bgal. Hyperleptinemia did not
significantly change insulin levels in either group; insulin aver-

aged 17.764.9 mU/ml in AdCMV-leptin–infused VMHL rats
and 10.262.8 mU/ml in SL rats.
Islet fat content and diabetes. Because the islets of ZDF
(fa/fa) rats are resistant to the lipopenic action of leptin, the fat
content of their pancreatic islets ranges from 10 to 100 times
normal (25). Islet fat exceeds 25–50 ng/islet at the time that diabetes begins, generally between 8–12 wk of age. If the islets of
VMHL rats are also resistant to the lipopenic action of leptin,
an increase in fat content and the appearance of diabetic abnormalities should have been evident. However, the islet TG
content of VMHL rats averaged only 19 ng/islet, not significantly different from that of SL controls, whereas islets of prediabetic ZDF (fa/fa) rats of similar age and weight contained
over twice as much fat (Fig. 3). This indicates that the islets of
VMHL rats must have been far more responsive to leptin in
vivo than the islets of ZDF (fa/fa) rats and almost as responsive as normal islets. However, whereas the genetic leptin resistance of ZDF (fa/fa) rats had existed throughout the 7 wk of
their life, the VMHL rats had been leptin-resistant for only 3
wk after their surgery. To determine if more prolonged leptin
resistance would cause accumulation of islet fat and diabetes, a
second group of five VMHL rats was sacrificed 12 wk after
VMH lesioning. The fat content of their islets averaged 21 ng/
islet, which is still not significantly above the SL controls.
Consistent with the lack of increased islet fat content in the
VMHL rats was the absence of overt diabetes during careful
observation up to the age of 20 wk. Although none of the rats
developed fasting hyperglycemia, their intraperitoneal glucose
tolerance test was slightly impaired (Table I). Thus, it appeared that the islets of VMHL rats escape the diabetogenic
consequences of leptin resistance, confirming earlier observations by others (14).
Skeletal muscle fat. We had previously reported that in leptin-resistant ZDF (fa/fa) rats, the TG content in islets is paralleled by an increase in the TG content of other tissues. In skeletal muscle for example, it rose to 13.8 ng/g/wet weight, which
is almost three times the normal content of 4.161.2 ng/g/wet
weight (20). This may have been a key factor in their insulin
resistance. For this reason, we measured skeletal muscle TG
content in VMHL rats. It averaged only 1.160.1 ng/g/wet

Figure 2. Food intake (A), body weight (B), plasma glucose in SL
and VMHL male Sprague Dawley rats (C), and food intake (D),
body weight (E), and plasma glucose (F) in ZDF (fa/fa) rats before
and 14 d after AdCMV-leptin or AdCMV-bgal infusion. Values represent the mean6SEM of five experiments.

Figure 3. Pancreatic islet triglyceride content of SL and VMHL
Sprague Dawley rats and ZDF (fa/fa) rats 14 d after AdCMV-leptin
or AdCMV-bgal infusion and 14 wk after VMHL of Sprague Dawley
rats. Values represent the mean6SEM of five rats. *P , 0.05 vs. SL
AdCMV-leptin–infused rats.
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Table I. Postprandial Plasma Glucose (PG), Triglyceride
(TG), Free Fatty Acids (FFA) Levels, and Glucose Tolerance
64 d after SL and VMHL of Male Sprague Dawley Rats

Plasma
PG (mg/dl)
TG (mg/dl)
FFA (mmol/l)
Time (h)
0
1
2

SL

VMHL

119.564.2
90.066.1
0.7760.09

93.863.5*
175.769.5‡
2.4760.49‡

103.363.9
238.3626.5
161.0614.7

92.262.4*
344.6614.0‡
287.8614.2‡

Data represent the mean6SEM of five experiments. Glucose was injected intraperitoneally in a dose of 2 g/kg/body weight. *P , 0.05 vs.
SL; ‡ P , 0.01 vs. SL.

weight, about the same as in normal rats made lipopenic by adenoviral leptin gene transfer (20). This low skeletal muscle fat
may have provided additional protection against diabetes by
increasing insulin sensitivity.
Effect of caloric restriction on in vivo leptin resistance of
VMHL rats. Since leptin resistance can be induced in normal
rodents by increasing their caloric intake (26), we wished to
eliminate any diet-induced impairment of leptin action in
VMHL rats. We therefore placed five hyperphagic VMHL rats
on a diet calorically matched to that of five SL controls and infused them with AdCMV-leptin. This diet matching had reduced their caloric intake by 28% prior to the infusion. Their
body weight averaged 32664.5 g 14 d after the infusion, compared with 421619 g in hyperleptinemic rats without dietary
restrictions (P , 0.01); however, this was not less than the
body weight of calorically matched uninfused VMHL rats
(without ectopic hyperleptinemia) and was significantly above
the hyperleptinemic SL rats (260613 g; P , 0.01) (Table II).
Thus, caloric restriction in VHML rats failed to reverse or reduce their resistance to the fat-depleting action of ectopic hyperleptinemia. In addition, the weight of their epididymal and
retroperitoneal fat depots was no less than that of uninfused
VMHL rats (Fig. 4).
Effects of VMHL on leptin action on islets in vitro. Earlier
studies had shown that leptin directly lowers TG content in
pancreatic islets from normal rats but has no effect in ZDF (fa/
fa) rats with defective leptin receptors. We therefore deter-

Figure 4. Wet weight of epididymal and retroperitoneal fat of SL and
VMHL animals calorically matched to SL Sprague Dawley rats 14 d
after AdCMV-leptin infusion or without infusion. Values represent
the mean6SEM of five experiments.

mined the in vitro effects of leptin on the TG content of cultured islets from VMHL rats, expecting it to be normal. However, the lipopenic activity of leptin in VMHL rats was only
50% of SL controls (Fig. 5). To determine if this leptin resistance was due to the ablative procedure itself, or if it was secondary to the increased food intake that follows VMHL, we
matched the caloric intake of a group of VMHL rats to that of
the SL rats for 2 wk beginning 4 d after the VMH ablation.
This reduced their caloric intake by 28%. This caloric matching resulted in a twofold increase in sensitivity to the lipopenic
action of leptin; the islets were now only 8% less sensitive than
SL controls in terms of lipopenic activity, and this difference
was not significant (NS).

Discussion
This study was designed to determine if obesity produced by
ablation of the VMH causes leptin resistance comparable to
that observed in ZDF (fa/fa) rats, in which a Glu 269 → Pro
mutation in the leptin receptor renders tissues completely resistant to the direct lipopenic effects of recombinant leptin
(16). Whereas the pancreatic islets of wild-type ZDF (1/1)
rats exhibit a . 70% reduction in fat intake when cultured in
the presence of 20 ng/ml of leptin, in islets from ZDF (fa/fa)
rats the elevated TG content is unresponsive to leptin at any

Table II. Plasma Leptin Levels and Body Weight 14 d after AdCMV-Infusion in SL, VMHL Sprague Dawley Rats Fed Ad
Libitum and VMHL Rats Calorically Matched to SL Control Rats
SL

Plasma leptin (ng/ml)
Body weight (g)

VMHL ad libitum

VMHL calorically matched to SL control

Control

AdCMV-leptin

Control

AdCMV-leptin

Control

AdCMV-leptin

0.9860.06
337611.5

14.561.5*
260612.6*

7.860.7*
395629.0

12.062.0‡
421619.4*

5.560.7*
31765.2

11.461.5§
32664.8

Data represent the mean6SEM of five experiments. *P , 0.01 vs. SL controls; ‡ P , 0.05 vs. VMHL ad libitum controls; § P , 0.01 vs. VMHL calorically matched controls.
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Figure 5. Pancreatic islet triglyceride content of islets of SL, VMHL
rats fed ad libitum, VMHL calorically matched to SL male Sprague
Dawley rats, and ZDF (fa/fa) rats. Islets were cultured for 2 d with or
without 20 ng/ml leptin. Values represent the mean6SEM of five experiments. *P , 0.05 vs. SL rats with leptin. †P , 0.05 vs. VMHL rats
fed ad libitum.

concentration (16). These findings led us to postulate that leptin acts not only via the hypothalamus but also via direct extrahypothalamic effects on tissues that express normal OB-R.
Since it seemed unlikely that a VMH lesion in otherwise normal rats would reduce either the level of expression or functional activity of OB-R in such target tissues, we expected that
the hyperphagia of VMHL rats would be resistant to the hyperleptinemia, but that adipocytes would be rapidly depleted
of fat, as in normal rats. This was not the case. Despite plasma
leptin values threefold above the control VMHL rats, neither
body weight nor the weight of epididymal and retroperitoneal
fat depots were reduced. Finally, although the normal fat content of their islets suggested that they had been sensitive to
leptin in vivo, the direct in vitro lipopenic action of leptin on islets from VMHL rats was only 50% that of SL controls, indicating a modest level of resistance.
Since increased caloric intake causes leptin resistance (26),
we reasoned that the increased caloric intake of the hyperphagic VMHL animals might be inducing peripheral resistance
unrelated to the ablation of the hypothalamic nuclei. To test
this hypothesis, the caloric intake of the hyperphagic VMHL
rats was matched to that of SL controls. This did not reduce either body weight or the weight of epididymal or retroperitoneal fat, but it did improve the lipopenic action of leptin on
isolated islets, bringing it to 92% of SL controls.
In contrast to the complete leptin resistance of ZDF (fa/fa)
rats, in which islet TG content ranges from 10 to 100 times normal, the TG content in islets of VMHL rats was only minimally
increased, about 10% above normal. In addition, skeletal muscle TG content, which is approximately three times normal in
ZDF (fa/fa) rats, was subnormal in VMHL rats. This could be
construed as evidence of sensitivity to leptin’s lipopenic action
in vivo. Since the islet cell dysfunction, insulin resistance, and
diabetes of ZDF (fa/fa) rats has been attributed to the accumulation of tissue fat (25), it was of interest to examine VMHL
rats for evidence of diabetes. In VMHL rats, there was no elevation in fasting glucose levels at any time during 90 d of observation, and their postprandial blood glucose levels, though
732
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normal, were lower than in the SL controls (Fig. 2 C). However, the intraperitoneal glucose tolerance test carried out 64 d
after lesioning revealed high levels at 1 and 2 h (Table I),
which may reflect modest insulin resistance and account for
the higher insulin levels of the VMHL rats.
The leptin resistance of VMHL rats is manifested by intense
hyperphagia and substantial weight gain despite hyperleptinemia. A further increase in hyperleptinemia caused by ectopic
leptin expression does not reduce food intake, body weight
gain, or weight of fat depots. When the food intake of AdCMVleptin–infused VMHL rats is calorically matched to SL controls
to eliminate leptin resistance secondary to high caloric intake,
there is still no apparent sensitivity to the ectopic hyperleptinemia in the form of a reduction in body weight or weight of fat
depots. Thus, the fat-depleting effect of hyperleptinemia is either mediated by the VMH through direct neuronal signaling
pathways or via a hypothalamic factor that directly or indirectly
renders adipocytes sensitive to direct action of leptin.
Islets isolated from VMHL rats on an unrestricted diet were
somewhat resistant to the lipopenic action of recombinant leptin; however, when the caloric intake of the VMHL rats was reduced to that of SL controls, there was marked improvement in
their sensitivity to the lipopenic action of leptin. This suggests
that the peripheral resistance of islets to leptin may in part be
the result of the high caloric intake rather than to the loss of
central regulatory factors originating from the VMH (27).
Clearly, the VMHL model of obesity differs strikingly from
the fa/fa ZDF model. Although the hyperphagia is similar in
the two, plasma and tissue lipids are considerably higher in the
ZDF rats. Since food intake averages about 30 g/d in both
groups of rats, it is likely that these differences reflect altered
metabolism of the ingested nutrients in the ZDF rats. We have
already established that lipogenesis is markedly increased in
their tissues (25), and more recently, we have found that expression of the enzymes of lipogenesis such as acetyl CoA carboxylase and fatty acid synthetase (Zhou, Y.-T., Y. Lee, K.
Koyama, T. Ferguson, and R.H. Unger, unpublished data) is
greatly increased. Since the increased lipogenesis can be reversed by expressing the wild-type leptin receptor in their tissues
(28), we speculate that in VMHL rats, overexpression of lipogenic enzymes and thus their lipogenic capacity is constrained by
a direct action of the hyperleptinemia on OB-R–expressing tissues. In ZDF rats, by contrast, these tissues are completely unresponsive to the hyperleptinemia, and the lack of any direct
leptin action results in a much greater lipogenic capacity.
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